ATC code D06
ATC code D06 Antibiotics and chemotherapeutics for dermatological use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup D06 is part of the anatomical group D Dermatologicals.[4]
| ATC codes |
|---|
| D Dermatologicals |
| D01 Antifungals for dermatological use |
| D02 Emollients and protectives |
| D03 Preparations for treatment of wounds and ulcers |
| D04 Antipruritics, including antihistamines, anesthetics, etc. |
| D05 Antipsoriatics |
| D06 Antibiotics and chemotherapeutics for dermatological use |
| D07 Corticosteroids, dermatological preparations |
| D08 Antiseptics and disinfectants |
| D09 Medicated dressings |
| D10 Anti-acne preparations |
| D11 Other dermatological preparations |
| ATCvet only |
| QD51 Products for the treatment of claws and hoofs |
|
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD06.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
D06A Antibiotics for topical use
D06AA Tetracycline and derivatives
- D06AA01 Demeclocycline
- D06AA02 Chlortetracycline
- D06AA03 Oxytetracycline
- D06AA04 Tetracycline
- QD06AA52 Chlortetracycline, combinations
- QD06AA53 Oxytetracycline, combinations
- QD06AA54 Tetracycline, combinations
D06AX Other antibiotics for topical use
- D06AX01 Fusidic acid
- D06AX02 Chloramphenicol
- D06AX04 Neomycin
- D06AX05 Bacitracin
- D06AX07 Gentamicin
- D06AX08 Tyrothricin
- D06AX09 Mupirocin
- D06AX10 Virginiamycin
- D06AX11 Rifaximin
- D06AX12 Amikacin
- D06AX13 Retapamulin
- D06AX14 Ozenoxacin
- D06AX15 Rifamycin
- QD06AX99 Other antibiotics for topical use, combinations
D06B Chemotherapeutics for topical use
D06BA Sulfonamides
- D06BA01 Silver sulfadiazine
- D06BA02 Sulfathiazole
- D06BA03 Mafenide
- D06BA04 Sulfamethizole
- D06BA05 Sulfanilamide
- D06BA06 Sulfamerazine
- QD06BA30 Combinations of chemotherapeutics for topical use
- D06BA51 Silver sulfadiazine, combinations
- QD06BA53 Mafenide, combinations
- QD06BA90 Formosulfathiazole
- QD06BA99 Sulfonamides, combinations
D06BB Antivirals
- D06BB01 Idoxuridine
- D06BB02 Tromantadine
- D06BB03 Aciclovir
- D06BB04 Podophyllotoxin
- D06BB05 Inosine
- D06BB06 Penciclovir
- D06BB07 Lysozyme
- D06BB08 Ibacitabine
- D06BB09 Edoxudine
- D06BB10 Imiquimod
- D06BB11 Docosanol
- D06BB12 Sinecatechins
- D06BB53 Aciclovir, combinations
D06BX Other chemotherapeutics
- D06BX01 Metronidazole
- D06BX02 Ingenol mebutate
- D06BX03 Tirbanibulin
D06C Antibiotics and chemotherapeutics, combinations
- Empty group
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code D06". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QD06". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.